Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.34/sh
Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.34), versus ($0.58) reported last year.
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.
Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.34), versus ($0.58) reported last year.
For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.